← All trials
NCT04990362
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2021
- Primary completion
- Dec 31, 2022
- Completion date
- Dec 31, 2022
- First posted
- Aug 4, 2021
- Last posted
- Aug 27, 2021
- Enrollment
- 60
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Aristotle University of ThessalonikiLead sponsor
- Aristotle University of ThessalonikiReponsible party - principal investigator
- Aristotle University of ThessalonikiOverall official - principal investigator
- Greek Alzheimer's Association and Related DisordersCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.